A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

117

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

November 30, 2012

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Anagliptin

Anagliptin 100mg, tablet, BID

DRUG

Anagliptin

Anagliptin 100mg, tablet, BID

DRUG

Placebo of Anagliptin

Placebo of Anagliptin 100mg, tablet, BID

Trial Locations (1)

Kangbuk Samsung Hospital, Seoul